Assignee
DRACO AB
SE39 patents
Top patents by PatentIndex Score
US4668218AMay 26, 1987
Indicating means for a dosage dispensing device
DRACO AB403 citations98
US4534345AAug 13, 1985
Dosage inhalator
DRACO AB211 citations98
US4524769AJun 25, 1985
Dosage inhalator
DRACO AB358 citations98
US4907583AMar 13, 1990
Device in powder inhalators
DRACO AB312 citations97
US4805811AFeb 21, 1989
Dosage device
DRACO AB152 citations97
US4667668AMay 26, 1987
Dosage inhalator
DRACO AB131 citations97
US4137914AFeb 6, 1979
Aerosol inhalation device
DRACO AB70 citations96
US4641644AFeb 10, 1987
Aerosol inhalation device
DRACO AB97 citations94
US5643602AJul 1, 1997
Oral composition for the treatment of inflammatory bowel disease
DRACO AB123 citations93
US4114615ASep 19, 1978
Aerosol inhalation device
DRACO AB115 citations93
US5331953AJul 26, 1994
Device in connection with an inhaler
DRACO AB339 citations92
US4804664AFeb 14, 1989
Method and pharmaceutical preparation for treating chronic obstructive airway disease and cardiac disease, and intermediates for the preparation of therapeutically active xanthine derivatives
DRACO AB28 citations91
US4693999ASep 15, 1987
Liposomes containing steroid esters
DRACO AB123 citations91
US4325956AApr 20, 1982
Method and pharmaceutical preparation for treating chronic obstructive airway disease and cardiac disease, and intermediates for the preparation of therapeutically active xanthine derivatives
DRACO AB35 citations91
US4174712ANov 20, 1979
Device for use with medicinal inhalation devices
DRACO AB47 citations91
US4011258AMar 8, 1977
Orally active bronchospasmolytic compounds
DRACO AB54 citations91
US3937838AFeb 10, 1976
Orally active bronchospasmolytic compounds and their preparation
DRACO AB58 citations91
US4419364ADec 6, 1983
Bronchospasmolytic carbamate derivatives
DRACO AB43 citations88
US4363806ADec 14, 1982
Pharmaceutical composition
DRACO AB69 citations88
US4292966AOct 6, 1981
Aerosol inhalation device
DRACO AB47 citations88
US4292324ASep 29, 1981
Aqueous zinc solutions for medical use
DRACO AB32 citations87
US4787536ANov 29, 1988
Dosage package
DRACO AB97 citations86
US5350767ASep 27, 1994
Derivatives of cysteine
DRACO AB18 citations75
US4233303ANov 11, 1980
Xanthine derivatives
DRACO AB22 citations75
US5531590AJul 2, 1996
Shock-stabilized supersonic flame-jet method and apparatus
DRACO AB15 citations74
US4644001AFeb 17, 1987
3-Alkylxanthines, composition and methods for the treatment of chronic obstructive-airway disease and cardiac disease
DRACO AB6 citations72
US4546182AOct 8, 1985
3,8-Dialkylxanthines
DRACO AB11 citations72
US4338319AJul 6, 1982
Method for the treatment of chronic obstructive airway or cardiac diseases
DRACO AB6 citations72
US6423340B1Jul 23, 2002
Method for the treatment of inflammatory bowel diseases
DRACO AB13 citations69
US4820700AApr 11, 1989
Novel androstane-17β-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions
DRACO AB11 citations69
US4404200ASep 13, 1983
4-Pregnene-derivatives, a process for their preparation, composition and method for the treatment of inflammatory conditions
DRACO AB10 citations69
US4442300AApr 10, 1984
Therapeutically active compounds
DRACO AB9 citations67
US4225614ASep 30, 1980
Method of treatment for mucocutaneous herpes simplex infections
DRACO AB18 citations60
US4451663AMay 29, 1984
Carbamate intermediates for bronchospasmolytics
DRACO AB4 citations58
US5215979AJun 1, 1993
16,17-acetalsubstituted pregnane 21-oic acid derivatives
DRACO AB3 citations57
US5350768ASep 27, 1994
Derivatives of cysteine
DRACO AB1 citations56
US4777255AOct 11, 1988
Process for preparing a purine derivative
DRACO AB0 citations50
US4950659AAug 21, 1990
16,17-acetalsubstituted androstane-17β-carboxylic acid esters prossessing high binding affinity to the glucocorticosteroid receptor
DRACO AB1 citations46
US4804656AFeb 14, 1989
Novel androstane-17β-carboxylic acid esters
DRACO AB1 citations46